Clemens Sommer Selected Research

Ischemic Stroke

1/2018	Dietary salt promotes ischemic brain injury and is associated with parenchymal migrasome formation.
3/2011	Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke.
10/2010	Neuroprotective effect of Fn14 deficiency is associated with induction of the granulocyte-colony stimulating factor (G-CSF) pathway in experimental stroke and enhanced by a pathogenic human antiphospholipid antibody.
2/2010	Pravastatin treatment causes a shift in the balance of hippocampal neurotransmitter binding densities towards inhibition.
1/2009	Different postischemic protein expression of the GABA(A) receptor alpha2 subunit and the plasticity-associated protein MAP1B after treatment with BDNF versus G-CSF in the rat brain.
12/2008	Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clemens Sommer Research Topics

Disease

18	Ischemia 01/2012 - 04/2002
17	Neoplasms (Cancer) 05/2024 - 02/2003
15	Stroke (Strokes) 01/2018 - 03/2003
13	Infarction (Infarctions) 01/2018 - 03/2003
10	Glioma (Gliomas) 02/2024 - 05/2003
10	Brain Ischemia (Cerebral Ischemia) 01/2011 - 03/2003
9	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 05/2003
6	Ischemic Stroke 01/2018 - 12/2008
5	Astrocytoma (Pilocytic Astrocytoma) 02/2024 - 05/2003
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2008 - 02/2004
3	Brain Neoplasms (Brain Tumor) 04/2022 - 08/2010
3	Wounds and Injuries (Trauma) 01/2021 - 01/2000
3	Neoplasm Metastasis (Metastasis) 12/2017 - 07/2003
3	Schizophrenia (Dementia Praecox) 11/2016 - 03/2010
3	Thrombosis (Thrombus) 10/2010 - 09/2006
2	Medulloblastoma 12/2022 - 01/2020
2	Neuroblastoma 12/2022 - 01/2008
2	Cerebral Hemorrhage 02/2021 - 10/2004
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 01/2014
2	Brain Injuries (Brain Injury) 01/2018 - 01/2012
2	Fibrosis (Cirrhosis) 01/2018 - 09/2006
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2012 - 06/2009
2	Brain Diseases (Brain Disorder) 03/2011 - 10/2010
2	Neuroinflammatory Diseases 03/2011 - 01/2011
2	Hemorrhage 09/2010 - 06/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2008 - 08/2005
1	cell-associated neurotoxicity 05/2024
1	Disease Progression 02/2024
1	Niemann-Pick Diseases (Niemann Pick Disease) 06/2023
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 03/2022
1	Hematoma 02/2021
1	Sciatic Neuropathy (Lesion of Sciatic Nerve) 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Fatigue 01/2019
1	Pathologic Processes 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 12/2016

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2002
6	LigandsIBA 05/2009 - 06/2002
5	Temozolomide (Temodar)FDA LinkGeneric 04/2022 - 09/2006
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 08/2005
5	CytokinesIBA 09/2013 - 12/2008
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2009 - 03/2003
5	AMPA Receptors (AMPA Receptor)IBA 03/2008 - 04/2002
4	Neuroprotective AgentsIBA 10/2010 - 05/2004
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 09/2006
3	Glutamic Acid (Glutamate)FDA Link 02/2010 - 06/2002
3	salicylhydroxamic acid (SHAM)IBA 06/2009 - 09/2006
3	Glutamate Receptors (Glutamate Receptor)IBA 03/2008 - 06/2002
3	N-Methylaspartate (NMDA)IBA 03/2008 - 06/2002
3	GABA-A Receptors (GABA(A) Receptor)IBA 03/2003 - 06/2002
3	MuscimolIBA 03/2003 - 06/2002
2	Glycoproteins (Glycoprotein)IBA 12/2023 - 07/2016
2	Contrast MediaIBA 11/2022 - 02/2003
2	Protein Isoforms (Isoforms)IBA 12/2021 - 03/2010
2	Arsenic Trioxide (Trisenox)FDA Link 08/2019 - 12/2016
2	AntibodiesIBA 01/2019 - 07/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 08/2010
2	Indicators and Reagents (Reagents)IBA 02/2017 - 01/2016
2	Messenger RNA (mRNA)IBA 11/2016 - 09/2003
2	O(6)-Methylguanine-DNA MethyltransferaseIBA 01/2016 - 11/2010
2	Nimodipine (Modus)FDA LinkGeneric 01/2012 - 06/2009
2	Antiphospholipid AntibodiesIBA 10/2010 - 09/2009
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 09/2006 - 06/2002
2	Dizocilpine Maleate (Dizocilpine)IBA 09/2006 - 06/2002
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 09/2006 - 01/2006
1	Chimeric Antigen ReceptorsIBA 05/2024
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2024
1	CeramidesIBA 06/2023
1	miglustat (Zavesca)FDA Link 06/2023
1	ceramide glucosyltransferaseIBA 06/2023
1	GlycosphingolipidsIBA 06/2023
1	GangliosidesIBA 12/2022
1	A-Form DNA (A-DNA)IBA 04/2022
1	Histones (Histone)IBA 04/2022
1	O-(6)-methylguanineIBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Peptides (Polypeptides)IBA 12/2021
1	Aldehyde Dehydrogenase 1 FamilyIBA 12/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	SolutionsIBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	Notch ReceptorsIBA 08/2019
1	Insulin ReceptorIBA 08/2019
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 08/2019
1	ceritinibIBA 08/2019
1	Insulin-Like PeptidesIBA 08/2019
1	AutoantibodiesIBA 01/2019
1	belimumabIBA 01/2019
1	Sodium Chloride FDA LinkGeneric 01/2018
1	SaltsIBA 01/2018
1	Circulating Tumor DNAIBA 12/2017

Therapy/Procedure

19	Therapeutics 12/2023 - 02/2004
4	Radiotherapy 01/2020 - 07/2003
3	Immunotherapy 05/2024 - 07/2016
2	Drug Therapy (Chemotherapy) 01/2020 - 09/2006
1	Stem Cell Transplantation 03/2022
1	Catheters 02/2021
1	Craniospinal Irradiation 01/2020